Harrow Health Inc
Change company Symbol lookup
Select an option...
HROW Harrow Health Inc
UPC Universe Pharmaceuticals Inc
MHH Mastech Digital Inc
GCTK GlucoTrack Inc
KODK Eastman Kodak Co
FYBR Frontier Communications Parent Inc
TPNEF Cub Energy Inc
ECC Eagle Point Credit Co LLC
CPHI China Pharma Holdings Inc
SHOP Shopify Inc
Go

Health Care : Pharmaceuticals | Small Cap Growth
Company profile

Harrow Health, Inc. is an ophthalmic-focused healthcare company. The Company's business specializes in the development, production and sale of medications that serve unmet needs in the marketplace through its subsidiaries and deconsolidated companies. The Company owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical business, and Visionology, Inc. (Visionology), a direct-to-consumer eye care subsidiary focused on chronic eye disease. In addition, the Company holds non-controlling equity positions in Surface Ophthalmics, Inc. (Surface) and Melt Pharmaceuticals, Inc. (Melt). It also owns royalty rights in various drug candidates being developed by Surface and Melt.

Closing Price
$8.44
Day's Change
0.17 (2.06%)
Bid
--
Ask
--
B/A Size
--
Day's High
8.68
Day's Low
8.29
Volume
(Average)
Volume:
65,848

10-day average volume:
66,952
65,848

Aurora Cannabis Inc. Stock Falls Friday, Underperforms Market

4:33 pm ET March 4, 2022 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Aurora Cannabis Inc. (ACB.T) slid 5.92% to $3.34 Friday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 1.66% to 13,313.44 and Dow Jones Industrial Average falling 0.53% to 33,614.80. This was the stock's second consecutive day of losses. Aurora Cannabis Inc. closed $8.08 short of its 52-week high ($11.42), which the company reached on March 16th.

The stock underperformed when compared to some of its competitors Friday, as Cronos Group Inc. (CRON.T) fell 3.33% to $3.19 and Tilray Brands Inc. Cl 2 (TLRY) fell 3.32% to $5.24. Trading volume (4.5 M) remained 1.4 million below its 50-day average volume of 5.9 M.

Data source: Dow Jones Market Data, FactSet. Data compiled March 4, 2022.

-MarketWatch Automation

	

(END) Dow Jones Newswires

March 04, 2022 16:33 ET (21:33 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.